Cash Isn't Always King: Stratasys, Omnicell, Clover Health

Cash-rich companies aren't always a safe bet! This episode reveals why a big pile of cash can mask deeper problems, spotlighting three companies—Stratasys, Omnicell, and Clover Health—whose net cash positions might be red flags. Learn why stagnant sales, shrinking profits, and ongoing cash burn make these companies potentially risky investments, and discover what to look for instead. Hosted on Acast. See acast.com/privacy for more information.